To access this element change to forms mode OFF
Grant Award View - GA177031-V1
Commercialisation of a novel brain pulse oximeter
GA ID:
GA177031-V1
Agency:
Department of Industry, Science and Resources
Approval Date:
9-Jun-2021
Variation Publish Date:
5-Aug-2021
Variation Date:
5-Aug-2021
Category:
Business Development
Grant Term:
9-Jul-2021 to 29-Mar-2027
Value (AUD):
$385,000.00
(GST inclusive where applicable)
Varies:
GA177031
- Commercialisation of a novel brain pulse oximeter
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DISR 21/22 Growing innovative & competitive bus, industries & regions
Grant Program:
Entrepreneurs' Programme – Accelerating Commercialisation
Grant Activity:
Commercialisation of a novel brain pulse oximeter
Purpose:
Cyban Pty Ltd is developing a product which provides non–invasive continuous monitoring of brain oxygen levels in critically ill patients with traumatic brain injury. This technology will reduce or eliminate secondary injuries due to hypoxia by allowing early detection and more importantly enable medical interventions for better patient outcomes. Accelerating Commercialisation support will be used to help Cyban commercialise the novel Brain Pulse Oximeter and ultimately achieve broad adoption of this technology, initially in the United States where the traumatic brain injury market is estimated at $800m, in addition to the burden associated with 26m new cases of traumatic brain injury globally per annum.
GO ID:
GO Title:
Entrepreneurs' Programme - Accelerating Commercialisation
Internal Reference ID:
ACGRANT000992
Selection Process:
Open Non-competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
CYBAN PTY LTD
Recipient ABN:
85 628 808 088
Grant Recipient Location
Suburb:
KEW
Town/City:
MELBOURNE
Postcode:
3101
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
3000
Country:
AUSTRALIA